KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Inventory (2016 - 2024)

Historic Change in Inventory for Nektar Therapeutics (NKTR) over the last 15 years, with Q4 2024 value amounting to -$1.3 million.

  • Nektar Therapeutics' Change in Inventory fell 2184.87% to -$1.3 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 39619.77%. This contributed to the annual value of -$497000.0 for FY2024, which is 2889.84% up from last year.
  • According to the latest figures from Q4 2024, Nektar Therapeutics' Change in Inventory is -$1.3 million, which was down 2184.87% from -$123000.0 recorded in Q3 2024.
  • In the past 5 years, Nektar Therapeutics' Change in Inventory ranged from a high of $2.4 million in Q4 2020 and a low of -$2.4 million during Q3 2023
  • For the 5-year period, Nektar Therapeutics' Change in Inventory averaged around $267050.0, with its median value being $389500.0 (2020).
  • Data for Nektar Therapeutics' Change in Inventory shows a peak YoY increase of 57037.91% (in 2023) and a maximum YoY decrease of 83862.07% (in 2023) over the last 5 years.
  • Nektar Therapeutics' Change in Inventory (Quarter) stood at $2.4 million in 2020, then crashed by 80.38% to $471000.0 in 2021, then plummeted by 69.21% to $145000.0 in 2022, then crashed by 838.62% to -$1.1 million in 2023, then decreased by 21.85% to -$1.3 million in 2024.
  • Its last three reported values are -$1.3 million in Q4 2024, -$123000.0 for Q3 2024, and -$212000.0 during Q2 2024.